Tivozanib Completed Phase 2 Trials for Recurrent Adult Soft Tissue Sarcoma / Stage III Adult Soft Tissue Sarcoma / Stage IV Adult Soft Tissue Sarcoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01782313A Phase II Study of Tivozanib in Patients With Metastatic and Non-resectable Soft Tissue Sarcomas